Second-look laparoscopy in ovarian cancer

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Diagnostic Imaging

Background:

• Epithelial ovarian cancer (EOC) management often involves multimodal therapy.
• Assessing treatment response and residual disease is crucial for patient outcomes.
• Second-look laparoscopy (SLL) is a minimally invasive technique for evaluating EOC patients post-treatment.

Purpose of the Study:

• To evaluate the role and efficacy of second-look laparoscopy in assessing residual disease in epithelial ovarian cancer patients.
• To determine the correlation between disease stage and the frequency of positive findings during SLL.
• To assess the safety and impact of SLL on subsequent management decisions.

Main Methods:

• Forty-six patients with previously treated epithelial ovarian cancer underwent SLL.
• Laparoscopic findings were categorized as positive (residual disease) or negative.
• Correlation between SLL findings, disease stage, and outcomes of subsequent laparotomy was analyzed.

Main Results:

• Twenty patients (43%) had positive SLL findings, avoiding further laparotomy.
• Twenty-six patients (57%) had negative SLL findings; 3 (12%) had residual disease detected at subsequent laparotomy.
• The frequency of positive findings was associated with the initial stage of ovarian cancer.
• SLL procedures were well-tolerated with no major complications.

Conclusions:

• Second-look laparoscopy is a valuable tool in the follow-up of epithelial ovarian cancer patients.
• SLL can accurately identify residual disease in a significant proportion of patients.
• While not a complete substitute for repeat laparotomy, SLL influences management decisions and patient follow-up strategies.